Cargando…
Socially optimal pandemic drug dosing
Autores principales: | Strohbehn, Garth W, Parker, William F, Reid, Pankti D, Gellad, Walid F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203182/ https://www.ncbi.nlm.nih.gov/pubmed/34139194 http://dx.doi.org/10.1016/S2214-109X(21)00251-5 |
Ejemplares similares
-
Targeted randomization dose optimization trials enable fractional dosing of scarce drugs
por: Boonstra, Philip S., et al.
Publicado: (2023) -
Dose optimisation and scarce resource allocation: two sides of the same coin
por: Strohbehn, Garth, et al.
Publicado: (2022) -
Social media: friend or foe in the COVID-19 pandemic?
por: Lima, Diego Laurentino, et al.
Publicado: (2020) -
Post-pandemic recovery: use of scientific advice to achieve social equity, planetary health, and economic benefits
por: Fears, Robin, et al.
Publicado: (2020) -
Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)